BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 22183171)

  • 1. Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria.
    Qian CD; Wu XC; Teng Y; Zhao WP; Li O; Fang SG; Huang ZH; Gao HC
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1458-65. PubMed ID: 22183171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.
    Schneider-Futschik EK; Paulin OKA; Hoyer D; Roberts KD; Ziogas J; Baker MA; Karas J; Li J; Velkov T
    ACS Infect Dis; 2018 May; 4(5):646-655. PubMed ID: 29566483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Paenibacillus strain produces a family of linear and cyclic antimicrobial lipopeptides: cyclization is not essential for their antimicrobial activity.
    Huang E; Yang X; Zhang L; Moon SH; Yousef AE
    FEMS Microbiol Lett; 2017 Apr; 364(8):. PubMed ID: 28333237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and partial characterization of cyclic lipopeptide antibiotics produced by Paenibacillus ehimensis B7.
    Huang Z; Hu Y; Shou L; Song M
    BMC Microbiol; 2013 Apr; 13():87. PubMed ID: 23594351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate.
    Pitt ME; Cao MD; Butler MS; Ramu S; Ganesamoorthy D; Blaskovich MAT; Coin LJM; Cooper MA
    J Antimicrob Chemother; 2019 Mar; 74(3):582-593. PubMed ID: 30445429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial activities and membrane-active mechanism of CPF-C1 against multidrug-resistant bacteria, a novel antimicrobial peptide derived from skin secretions of the tetraploid frog Xenopus clivii.
    Xie J; Gou Y; Zhao Q; Wang K; Yang X; Yan J; Zhang W; Zhang B; Ma C; Wang R
    J Pept Sci; 2014 Nov; 20(11):876-84. PubMed ID: 25098547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of a Paenibacillus sp. strain and structural elucidation of its broad-spectrum lipopeptide antibiotic.
    Guo Y; Huang E; Yuan C; Zhang L; Yousef AE
    Appl Environ Microbiol; 2012 May; 78(9):3156-65. PubMed ID: 22367082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity.
    Wang T; Zheng Y; Dai J; Zhou J; Yu R; Zhang C
    Microbiol Spectr; 2021 Dec; 9(3):e0054621. PubMed ID: 34878337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the Interaction of Octapeptin A3 with Model Bacterial Membranes.
    Han ML; Shen HH; Hansford KA; Schneider EK; Sivanesan S; Roberts KD; Thompson PE; Le Brun AP; Zhu Y; Sani MA; Separovic F; Blaskovich MAT; Baker MA; Moskowitz SM; Cooper MA; Li J; Velkov T
    ACS Infect Dis; 2017 Aug; 3(8):606-619. PubMed ID: 28695731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potent antibacterial activity of new short d-enantiomeric lipopeptide against multi drug resistant bacteria.
    Lee J; Kim S; Sim JY; Lee D; Kim HH; Hwang JS; Lee DG; Park ZY; Kim JI
    Biochim Biophys Acta Biomembr; 2019 Jan; 1861(1):34-42. PubMed ID: 30393205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741.
    Corbett D; Wise A; Langley T; Skinner K; Trimby E; Birchall S; Dorali A; Sandiford S; Williams J; Warn P; Vaara M; Lister T
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure, Function, and Biosynthetic Origin of Octapeptin Antibiotics Active against Extensively Drug-Resistant Gram-Negative Bacteria.
    Velkov T; Gallardo-Godoy A; Swarbrick JD; Blaskovich MAT; Elliott AG; Han M; Thompson PE; Roberts KD; Huang JX; Becker B; Butler MS; Lash LH; Henriques ST; Nation RL; Sivanesan S; Sani MA; Separovic F; Mertens H; Bulach D; Seemann T; Owen J; Li J; Cooper MA
    Cell Chem Biol; 2018 Apr; 25(4):380-391.e5. PubMed ID: 29396290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?
    Blaskovich MAT; Pitt ME; Elliott AG; Cooper MA
    Expert Rev Anti Infect Ther; 2018 Jun; 16(6):485-499. PubMed ID: 29848132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and identification of lipopeptide antibiotics from Paenibacillus elgii B69 with inhibitory activity against methicillin-resistant Staphylococcus aureus.
    Ding R; Wu XC; Qian CD; Teng Y; Li O; Zhan ZJ; Zhao YH
    J Microbiol; 2011 Dec; 49(6):942-9. PubMed ID: 22203557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paenibacterin, a novel broad-spectrum lipopeptide antibiotic, neutralises endotoxins and promotes survival in a murine model of Pseudomonas aeruginosa-induced sepsis.
    Huang E; Yousef AE
    Int J Antimicrob Agents; 2014 Jul; 44(1):74-7. PubMed ID: 24802906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dilipid ultrashort cationic lipopeptides as adjuvants for chloramphenicol and other conventional antibiotics against Gram-negative bacteria.
    Domalaon R; Brizuela M; Eisner B; Findlay B; Zhanel GG; Schweizer F
    Amino Acids; 2019 Mar; 51(3):383-393. PubMed ID: 30392097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activities and action mechanism studies of transportan 10 and its analogues against multidrug-resistant bacteria.
    Xie J; Gou Y; Zhao Q; Li S; Zhang W; Song J; Mou L; Li J; Wang K; Zhang B; Yang W; Wang R
    J Pept Sci; 2015 Jul; 21(7):599-607. PubMed ID: 25891396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of octapeptin C4 and biological profiling against NDM-1 and polymyxin-resistant bacteria.
    Becker B; Butler MS; Hansford KA; Gallardo-Godoy A; Elliott AG; Huang JX; Edwards DJ; Blaskovich MAT; Cooper MA
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2407-2409. PubMed ID: 28454673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.